Philip Düsing

429 total citations · 1 hit paper
16 papers, 280 citations indexed

About

Philip Düsing is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Philip Düsing has authored 16 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Cancer Research. Recurrent topics in Philip Düsing's work include Extracellular vesicles in disease (6 papers), Sphingolipid Metabolism and Signaling (4 papers) and MicroRNA in disease regulation (3 papers). Philip Düsing is often cited by papers focused on Extracellular vesicles in disease (6 papers), Sphingolipid Metabolism and Signaling (4 papers) and MicroRNA in disease regulation (3 papers). Philip Düsing collaborates with scholars based in Germany and India. Philip Düsing's co-authors include Georg Nickenig, Felix Jansen, Andreas Zietzer, Mohammed Rabiul Hosen, Philip Roger Goody, Christian Kurts, Peter Dörmann, Katharina Gutbrod, Nikos Werner and Baravan Al‐Kassou and has published in prestigious journals such as European Heart Journal, Arteriosclerosis Thrombosis and Vascular Biology and Cellular and Molecular Life Sciences.

In The Last Decade

Philip Düsing

16 papers receiving 277 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches

2021 128 citations Philip Düsing, Andreas Zietzer et al. Journal of Molecular Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip Düsing Germany	7	114	71	61	53	39	16	280
Sara A. Murphy United States	7	166 1.5×	70 1.0×	43 0.7×	54 1.0×	53 1.4×	13	367
Ronald St-Louis United States	8	87 0.8×	56 0.8×	115 1.9×	52 1.0×	57 1.5×	13	341
Guangyao Zang China	10	198 1.7×	61 0.9×	27 0.4×	33 0.6×	65 1.7×	22	340
Xinxin Pang China	13	145 1.3×	30 0.4×	88 1.4×	53 1.0×	38 1.0×	19	333
Wendy Beattie United Kingdom	8	118 1.0×	36 0.5×	31 0.5×	22 0.4×	35 0.9×	15	319
Marina Sokolova Norway	6	165 1.4×	73 1.0×	20 0.3×	73 1.4×	33 0.8×	11	286
Xiaogao Jin China	11	103 0.9×	25 0.4×	95 1.6×	54 1.0×	41 1.1×	19	334
Keisuke Yatsu Japan	11	65 0.6×	90 1.3×	51 0.8×	22 0.4×	23 0.6×	21	264
Hai-Ying Qi China	6	168 1.5×	35 0.5×	157 2.6×	48 0.9×	48 1.2×	12	403

Countries citing papers authored by Philip Düsing

Since Specialization

Citations

This map shows the geographic impact of Philip Düsing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Düsing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Düsing more than expected).

Fields of papers citing papers by Philip Düsing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Düsing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Düsing. The network helps show where Philip Düsing may publish in the future.

Co-authorship network of co-authors of Philip Düsing

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Düsing. A scholar is included among the top collaborators of Philip Düsing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Düsing. Philip Düsing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Düsing, Philip, Stephan H. Schirmer, Sebastian Daniel Schäfer, et al.. (2025). A smartphone-guided secondary prevention digital health application reduces systolic blood pressure in patients with chronic coronary syndrome and insufficient blood pressure control. Frontiers in Cardiovascular Medicine. 12. 1515598–1515598. 1 indexed citations

Düsing, Philip, Patrick Giavalisco, Frederik Dethloff, et al.. (2025). The role of uremic toxin indoxyl sulfate in the pathophysiology of aortic valve stenosis. Cardiovascular Research. 121(11). 1734–1749. 1 indexed citations

Niepmann, Sven Thomas, Philip Düsing, Thomas Beiert, et al.. (2024). Loss of ceramide synthase 5 inhibits the development of experimentally induced aortic valve stenosis. Acta Physiologica. 240(5). e14140–e14140. 2 indexed citations

Düsing, Philip, Stephan H. Schirmer, Jan‐Malte Sinning, et al.. (2023). A prospective, randomized, controlled, multicentre trial for secondary prevention in patients with chronic coronary syndrome using a smartphone application for digital therapy: the CHANGE study protocol. European Heart Journal - Digital Health. 4(3). 207–215. 3 indexed citations

Düsing, Philip, Baravan Al‐Kassou, Katharina Gutbrod, et al.. (2023). Analysis of circulating ceramides and hexosylceramides in patients with coronary artery disease and type II diabetes mellitus. BMC Cardiovascular Disorders. 23(1). 454–454. 10 indexed citations

Zietzer, Andreas, Philip Düsing, Jens Peter Klußmann, et al.. (2022). The lncRNA MRPL20-AS1 is associated with severe OSAS and downregulated upon hypoxic injury of endothelial cells. International Journal of Cardiology. 369. 65–68. 7 indexed citations

Düsing, Philip, et al.. (2022). Smart devices resulting in big effect: can apps cure heart disease?. European Heart Journal. 43(21). 2003–2004. 1 indexed citations

Zietzer, Andreas, et al.. (2022). Ceramide Metabolism in Cardiovascular Disease: A Network With High Therapeutic Potential. Arteriosclerosis Thrombosis and Vascular Biology. 42(10). 1220–1228. 53 indexed citations

Zietzer, Andreas, Katharina Gutbrod, Philip Düsing, et al.. (2021). Activation of neutral sphingomyelinase 2 through hyperglycemia contributes to endothelial apoptosis via vesicle-bound intercellular transfer of ceramides. Cellular and Molecular Life Sciences. 79(1). 48–48. 15 indexed citations

10.

Düsing, Philip, Andreas Zietzer, & Felix Jansen. (2021). MicroRNA-Based Diagnostics in Heart Diseases. JACC Basic to Translational Science. 6(11). 897–899. 1 indexed citations

11.

Düsing, Philip, Andreas Zietzer, Philip Roger Goody, et al.. (2021). Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches. Journal of Molecular Medicine. 99(3). 335–348. 128 indexed citations breakdown →

12.

Goody, Philip Roger, Mohammed Rabiul Hosen, Neda Mohammadi, et al.. (2021). NcRNAs in Vascular and Valvular Intercellular Communication. Frontiers in Molecular Biosciences. 8. 749681–749681. 4 indexed citations

13.

Düsing, Philip, Andreas Zietzer, & Felix Jansen. (2021). MicroRNA-Based Diagnostics in Heart Diseases: Current Limitations and Future Perspectives. 1 indexed citations

14.

Zietzer, Andreas, Sven Thomas Niepmann, Philip Düsing, et al.. (2020). MicroRNA-mediated vascular intercellular communication is altered in chronic kidney disease. Cardiovascular Research. 118(1). 316–333. 24 indexed citations

15.

Shamekhi, Jasmin, et al.. (2019). Healing a Heart of Stone. JACC: Cardiovascular Interventions. 13(4). 532–533. 5 indexed citations

16.

Schwarz, Viktoria, Philip Düsing, Thomas Liman, et al.. (2017). Marathon running increases circulating endothelial- and thrombocyte-derived microparticles. European Journal of Preventive Cardiology. 25(3). 317–324. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact